Search Results - Gajewski, Thomas
- Showing 1 - 2 results of 2
-
1
Targeting molecular pathways to control immune checkpoint inhibitor toxicities by Reschke, Robin Niklas (Author) , Sullivan, Ryan J. (Author) , Lipson, Evan J. (Author) , Enk, Alexander (Author) , Gajewski, Thomas F. (Author) , Hassel, Jessica C. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients by Pearson, Andrew D. J. (Author) , Rossig, Claudia (Author) , Lesa, Giovanni (Author) , Diede, Scott J. (Author) , Weiner, Susan (Author) , Anderson, John (Author) , Gray, Juliet (Author) , Geoerger, Birgit (Author) , Minard-Colin, Veronique (Author) , Marshall, Lynley V. (Author) , Smith, Malcolm (Author) , Sondel, Paul (Author) , Bajars, Marcis (Author) , Baldazzi, Claudia (Author) , Barry, Elly (Author) , Blackman, Sam (Author) , Blanc, Patricia (Author) , Capdeville, Renaud (Author) , Caron, Hubert (Author) , Cole, Peter D. (Author) , Jiménez, Jorge Camarero (Author) , Demolis, Pierre (Author) , Donoghue, Martha (Author) , Elgadi, Mabrouck (Author) , Gajewski, Thomas (Author) , Galluzzo, Sara (Author) , Ilaria, Robert (Author) , Jenkner, Alessandro (Author) , Karres, Dominik (Author) , Kieran, Mark (Author) , Ligas, Franca (Author) , Lowy, Israel (Author) , Meyers, Michael (Author) , Oprea, Corina (Author) , Peddareddigari, Vijay G. R. (Author) , Sterba, Jaroslav (Author) , Stockman, Paul K. (Author) , Suenaert, Peter (Author) , Tabori, Uri (Author) , Tilburg, Cornelis M. van (Author) , Yancey, Todd (Author) , Weigel, Brenda (Author) , Norga, Koenraad (Author) , Reaman, Gregory (Author) , Vassal, Gilles (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource
Search Tools:
Related Subjects
Antineoplastic Agents
B7-H1 Antigen
CTLA-4 Antigen
Child
Drug Development
Drug Therapy, Combination
Government Agencies
Humans
Immune checkpoint inhibitors
Immunotherapy
Medicinal product development
Needs Assessment
Neoplasms
Paediatric oncology
Patient Care Planning
Prognosis
immune-related adverse events
immunotherapy
personalized medicine
targeted therapy
toxicities